Researchers help explain elusive mechanics of complex cell transport system

Every cell in the human body contains a complex system to transport essential cargoes such as proteins and membrane vesicles, from point A to point B. These tiny molecular motor proteins move at blistering speeds on miniature railways carrying components of the cell to their proper destinations. But just how cells construct these transport railways to fit precisely inside of confined spaces of the individual cells has been a complex question, as it is critical that these railways do not grow too long or come up too short, as that would cause a misdirection of the proteins being transported.

Bruce Goode, professor of biology, working in collaboration with the labs of Laurent Blanchoin (Grenoble, France) and Roland Wedlich-Soldner (Munich, Germany), have come one step closer to understanding the elusive mechanics of this process.

In a recent paper published in Developmental Cell, a team led by Goode's Ph.D. student Melissa Chesarone-Cataldo shows that the length of the railways is controlled by one of its "passengers," which pauses during the journey to communicate with the machinery that is building the railways.

"The frequency of these chats between the passengers and builders may provide the feedback necessary to say a railway is long enough, and construction should now slow down," says Goode.

Much like a real construction site, a system must be in place with roadways and transporters to move the building materials. In this case, cellular proteins called actin cables act as the roadways, and the transporters are myosin molecules, nanoscale motor proteins that rapidly deliver critical cargoes to one end of a cell. Each cable is assembled from hundreds or thousands of copies of the actin, which is called a helical filament.

Nine years ago, Goode and his colleagues discovered that a family of proteins called formins stimulate the rapid growth of actin filaments. Recently, the team began to question how a cell controls the power of formins, which tell them when to speed up, when to slow down, when to stop altogether.

Enter Smy1, a myosin-passenger protein.

Goode and his colleagues hypothesized that a passenger protein like Smy1 would provide the perfect mechanism for slowing down formins when roadways are longer and would be carrying more passengers. They tested their theory in yeast cells, where formins construct actin cables that transport building materials essential for cell growth and division. As Goode says, they struck gold.

When they deleted the gene for Smy1, cables grew abnormally fast and hit the back of the cell, buckling and misdirecting transport. When they purified Smy1 and placed it in a test tube with formins they discovered that Smy1 slows down actin filament growth.

To further explore, they tagged Smy1 in living cells and learned that Smy1 molecules are carried on cables by myosin to the formin, where they pause for 1-2 seconds to give formins the message to slow down.

Goode says their working model illustrates that as a cable grows longer, it loads up more and more Smy1 molecules, which are transported on the cable to send a message to the formin to slow down.

"This prevents overgrowth of longer cables that are nearing the back of the cell, but allows rapid growth of the shorter cables," says Goode.

This paper will help scientists understand the general mechanisms that are used for directing cell shape and division. The next challenge says Goode, is "to find out whether related mechanisms are used to control formins in mammalian cells and understand the physiological consequences of disrupting those mechanisms."

Source: Brandeis University

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Breakthrough discovery opens doors for targeting adhesion GPCRs with drugs